Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New herpes collaboration between Astra and Medivir

Feb. 24, 1998

Floxin Otic launched in U.S.

Feb. 24, 1998

Clinical status of CS-834

Feb. 23, 1998

Idec RSV antibodies covered by U.S. patents; development partners sought

Feb. 23, 1998

Rifaximin receives orphan drug status in hepatic encephalopathy

Feb. 23, 1998

SKB evaluates RF-1 as antibacterial target

Feb. 23, 1998

Advisory panel recommends approval of Synercid

Feb. 20, 1998

Glaxo Wellcome enrolls patients in phase III flu drug trials

Feb. 20, 1998

Shionogi investigates new cephem compounds

Feb. 19, 1998

KY-62 evaluated in murine models of candidiasis

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.